IGC Stock Analysis: Buy, Sell, or Hold?
IGC - IGC Pharma, Inc.
$0.27
0.00 (1.52%)
▲
5d:
-5.65%
30d:
-2.59%
90d:
-31.48%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Feb 13, 2026
9d
Get Alerted When IGC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IGC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IGC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IGC is currently trading at $0.27, which is considered oversold relative to its 30-day fair value range of $0.28 to $0.30.
Technical Outlook: Technically, IGC is in a strong downtrend. The price is currently testing key support at $0.27. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IGC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.88 (+1313.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IGC is in a strong downtrend. The price is currently testing key support at $0.27. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IGC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.88 (+1313.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.28 -
$0.30
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1313.7% below Wall St target ($3.88)
- CAUTION: 5-day price weakness (-5.6%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.28 -
$0.30
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.27
Resistance Level
$0.31
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.05
Wall Street Target
$3.88
(+1313.7%)
Revenue Growth (YoY)
-53.6%
Last updated: February 03, 2026 8:22 AM ET
Data refreshes hourly during market hours. Next update: 9:22 AM
Data refreshes hourly during market hours. Next update: 9:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IGC showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 61 BUY |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 61 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$140 | 52 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 53 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 57 HOLD |
